Chemotherapy does not affect complication rate or patient satisfaction for breast reconstruction

Among those who underwent a mastectomy and breast reconstruction, there were no significant differences in complication rate or patient well-being for women who received chemotherapy as an additional treatment compared to those who did not.

11:00 AM

Author | Mary Clare Fischer

chemo medicine bags hanging on IV pole with lab note badge in yellow in background
Getty Images

Receiving chemotherapy as additional treatment for breast cancer did not increase the complication rate for women who underwent a mastectomy and a breast reconstruction as part of the same operation, University of Michigan researchers found.

Chemotherapy didn't affect the patients' well-being or their level of satisfaction with the procedure either.

The Mastectomy Reconstruction Outcomes Consortium Study is the first to examine this topic in a large number of patients at multiple health centers.

"One in eight women will be diagnosed with breast cancer during her lifetime, and the number of women undergoing mastectomy for breast cancer has increased over time," said Sarah E. Hart, M.D., the first author of the study and a plastic surgery resident at Michigan Medicine, the academic medical center of the University of Michigan. "The information from this study can assist patients and providers in informed decision making for breast reconstruction in the setting of chemotherapy."

Previous research led by Michigan Medicine has shown that radiation after breast reconstruction is linked to both higher complication rates and lower patient satisfaction.

Paper cited/DOI: "Impact of Chemotherapy on Clinical Complications and Patient-reported Outcomes after 1 Immediate Breast Reconstruction," JAMA Surgery.


More Articles About: Lab Notes Chemotherapy Reconstructive Surgery Post Operative and Recovery Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Father’s cancerous brain tumor found weeks after the birth of his daughter
Father’s cancerous brain tumor found weeks after the birth of his daughter
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.